Botong Li

机构：Gansu University of Traditional Chinese Medicine · ORCID：0009-0008-6561-5627

发表论文 14 篇 · 总被引 186 次 · h-index 7

代表论文

• Natural products targeting Nrf2/ARE signaling pathway in the treatment of inflammatory bowel disease (2023 · Biomedicine & Pharmacotherapy · 被引 43)
• Using Drosophila melanogaster as a suitable platform for drug discovery from natural products in inflammatory bowel disease (2022 · Frontiers in Pharmacology · 被引 36)
• Drosophila as a Model to Study the Mechanism of Nociception (2022 · Frontiers in Physiology · 被引 33)
• Protective effect of San Huang Pill and its bioactive compounds against ulcerative colitis in Drosophila via modulation of JAK/STAT, apoptosis, Toll, and Nrf2/Keap1 pathways (2023 · Journal of Ethnopharmacology · 被引 21)
• Caffeic Acid Protects Against Ulcerative Colitis via Inhibiting Mitochondrial Apoptosis and Immune Overactivation in Drosophila (2025 · Drug Design Development and Therapy · 被引 15)
• Lactobacillus rhamnosus GR-1 Alleviates Escherichia coli-Induced Inflammation via NF-κB and MAPKs Signaling in Bovine Endometrial Epithelial Cells (2022 · Frontiers in Cellular and Infection Microbiology · 被引 15)